Compartir
Rethinking Cancer: A new Paradigm for the Postgenomics era (Vienna Series in Theoretical Biology) (en Inglés)
Bernhard Strauss
(Ilustrado por)
·
Marta Bertolaso
(Ilustrado por)
·
Ingemar Ernberg
(Ilustrado por)
·
MIT Press
· Tapa Dura
Rethinking Cancer: A new Paradigm for the Postgenomics era (Vienna Series in Theoretical Biology) (en Inglés) - Strauss, Bernhard ; Bertolaso, Marta ; Ernberg, Ingemar
$ 50.710
$ 84.510
Ahorras: $ 33.800
Elige la lista en la que quieres agregar tu producto o crea una nueva lista
✓ Producto agregado correctamente a la lista de deseos.
Ir a Mis Listas
Origen: Estados Unidos
(Costos de importación incluídos en el precio)
Se enviará desde nuestra bodega entre el
Miércoles 05 de Junio y el
Miércoles 12 de Junio.
Lo recibirás en cualquier lugar de Chile entre 1 y 3 días hábiles luego del envío.
Reseña del libro "Rethinking Cancer: A new Paradigm for the Postgenomics era (Vienna Series in Theoretical Biology) (en Inglés)"
Leading scientists argue for a new paradigm for cancer research, proposing a complex systems view of cancer supported by empirical evidence. Current consensus in cancer research explains cancer as a disease caused by specific mutations in certain genes. After dramatic advances in genome sequencing, never before have we known so much about the individual cancer cell--and yet never before has it been so unclear what to do with this knowledge. In this volume, leading researchers argue for a new theory framework for understanding and treating cancer. The contributors propose a complex systems view of cancer, presenting conceptual building blocks for a new research paradigm supported by empirical evidence. The contributors first discuss the new research framework in terms of theoretical foundations and then take up the relevance of a systems approach, reviewing such topics as nonlinearity, recurrence after treatment, the cellular attractor concept, network theory, and non-coding DNA--the dark matter of our genome. They address the temporality of cancer progression, drawing on evolutionary theory and clinical experience. Finally, they cover the dominant role of the tissue microenvironment in cancer, analyzing topics including altered metabolic pathways, the disease-defining influence on metastasis, and the interconnectedness of different environmental niches across levels of organization.
